Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karen E. Giles"'
Autor:
Jennifer M. Knight, Stephanie A. Kerswill, Parameswaran Hari, Steve W. Cole, Brent R. Logan, Anita D’Souza, Nirav N. Shah, Mary M. Horowitz, Melinda R. Stolley, Erica K. Sloan, Karen E. Giles, Erin S. Costanzo, Mehdi Hamadani, Saurabh Chhabra, Binod Dhakal, J. Douglas Rizzo
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Repurposing existing medications for antineoplastic purposes can provide a safe, cost-effective, and efficacious means to further augment available cancer care. Clinical and preclinical studies suggest a role for the ß-adrenergic
Externí odkaz:
https://doaj.org/article/83c55287993342728511687fa8453133
Autor:
Jamie Aranda, Goundappa K Balasubramani, Ritu Banerjee, Behin Barahimi, Laura A. Binari, David M. Brooks, Anna Burgner, Alexander De Castro-Abeger, Matthew Chinn, Amparo de la Peña, Ally Esch, Mark E. Garcia, Ben Geoffrey A.S., Pravin George, Karen E. Giles, Aarthi Goverdhan, Daniel Griffin, Sylvia Groth, Madihah Hepburn, Nancy Jacobson, Sarah Kim, Charles A. Knirsch, Srinivasan Krishnaswami, Sriram Krishnaswami, Pooja Lal, Susan M. Lopata, Subramani Mani, Natalie N. McCall, William M. McDonald, Sujatha S. Menon, Cullen P. Moran, Sivakumar Nagaraju, Christopher Newey, Mary Patricia Nowalk, Dhyanesh A. Patel, Amelie Pham, Krishna Ramakrishnamenon Prasad, Sathishkumar Ramalingam, John C. Ray, Mythily Srinivasan, Amit K. Srivastava, Jennifer L. Thompson, Thankam Thyvalikakath, Michael F. Vaezi, Andreas Wack, Robert S. Wallis, Charles B. Nemeroff, Jörn-Hendrik Weitkamp
Publikováno v:
Textbook of SARS-CoV-2 and COVID-19 ISBN: 9780323875394
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd94c6282691bb93435208c78346e4ca
https://doi.org/10.1016/b978-0-323-87539-4.00029-4
https://doi.org/10.1016/b978-0-323-87539-4.00029-4
Publikováno v:
Textbook of SARS-CoV-2 and COVID-19 ISBN: 9780323875394
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ac2e35ce8bcce0cbabaf62ab83911b6
https://doi.org/10.1016/b978-0-323-87539-4.00012-9
https://doi.org/10.1016/b978-0-323-87539-4.00012-9
Autor:
Mehdi Hamadani, Nirav N. Shah, Marcelo C. Pasquini, J. Douglas Rizzo, Steve W. Cole, Deepika Sriram, Saurabh Chhabra, Parameswaran Hari, Binod Dhakal, Brent R. Logan, Anita D'Souza, Jennifer M. Knight, Mary M. Horowitz, Karen E. Giles
Publikováno v:
Blood Advances. 4:467-476
Preclinical research shows that stress-induced activation of the sympathetic nervous system can promote hematopoietic malignancies via β-adrenoreceptor–mediated molecular pathways. Hematopoietic cell transplant (HCT) recipients exposed to conditio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39538599dd55bf572c987777aeb32c7d
https://doi.org/10.1182/bloodadvances.2019000765
https://doi.org/10.1182/bloodadvances.2019000765
Autor:
Ziyan Yin, William R. Drobyski, J D Rizzo, Aniko Szabo, Erin S. Costanzo, Cecilia J. Hillard, Jennifer M. Knight, Christopher L. Coe, Anita D'Souza, Suraj Singh, Karen E. Giles
Publikováno v:
Brain, Behavior, and Immunity. 76:e22-e23
Historically, sickness symptomatology in cancer patients has been studied as aggregated phenomena arising from a similar inflammatory etiology. A parent clinical trial analyzed depression, anxiety, fatigue, sleep, and pain as separate variables in he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06dd6cd577bb920e5150ec6c1e58493b
https://doi.org/10.1016/j.bbi.2018.11.243
https://doi.org/10.1016/j.bbi.2018.11.243
Autor:
Binod Dhakal, Saurabh Chhabra, Mary M. Horowitz, Parameswaran Hari, Erica K. Sloan, Erin S. Costanzo, Brent R. Logan, Anita D'Souza, Stephanie A. Kerswill, Nirav N. Shah, Jennifer M. Knight, Karen E. Giles, J. Douglas Rizzo, Steve W. Cole, Melinda R. Stolley, Mehdi Hamadani
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Background Repurposing existing medications for antineoplastic purposes can provide a safe, cost-effective, and efficacious means to further augment available cancer care. Clinical and preclinical studies suggest a role for the ß-adrenergic antagoni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d791f02b25c065a7dc920c128a6976c
https://pubmed.ncbi.nlm.nih.gov/29793446
https://pubmed.ncbi.nlm.nih.gov/29793446
Autor:
Namrata Shah, Steve W. Cole, B. Dhaka, P. Hari, Saurabh Chhabra, Brent R. Logan, Anita D'Souza, Marcelo C. Pasquini, Karen E. Giles, Mehdi Hamadani, Jennifer M. Knight, J D Rizzo
Publikováno v:
Brain, Behavior, and Immunity. 76:e4
Beta-adrenergic signaling regulates multiple molecular pathways that contribute to cancer progression; beta-adrenergic antagonists efficiently block many of these effects in animals. We previously demonstrated that hematopoietic cell transplant (HCT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8498b70236085e4b2146924abf9fccc7
https://doi.org/10.1016/j.bbi.2018.11.183
https://doi.org/10.1016/j.bbi.2018.11.183